HK1197085A1 - Genetic variants for predicting risk of breast cancer - Google Patents

Genetic variants for predicting risk of breast cancer

Info

Publication number
HK1197085A1
HK1197085A1 HK14110581A HK14110581A HK1197085A1 HK 1197085 A1 HK1197085 A1 HK 1197085A1 HK 14110581 A HK14110581 A HK 14110581A HK 14110581 A HK14110581 A HK 14110581A HK 1197085 A1 HK1197085 A1 HK 1197085A1
Authority
HK
Hong Kong
Prior art keywords
breast cancer
genetic variants
predicting risk
predicting
risk
Prior art date
Application number
HK14110581A
Other languages
English (en)
Chinese (zh)
Inventor
Patrick Sulem
Simon Stacey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1197085A1 publication Critical patent/HK1197085A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK14110581A 2011-06-16 2014-10-23 Genetic variants for predicting risk of breast cancer HK1197085A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IS50016 2011-06-16
PCT/IS2012/050009 WO2012172575A1 (en) 2011-06-16 2012-06-14 Genetic variants for predicting risk of breast cancer

Publications (1)

Publication Number Publication Date
HK1197085A1 true HK1197085A1 (en) 2015-01-02

Family

ID=47356620

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14110581A HK1197085A1 (en) 2011-06-16 2014-10-23 Genetic variants for predicting risk of breast cancer

Country Status (4)

Country Link
US (1) US20140329719A1 (xx)
EP (1) EP2721180A4 (xx)
HK (1) HK1197085A1 (xx)
WO (1) WO2012172575A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015035415A1 (en) * 2013-09-09 2015-03-12 Nantomics, Llc Method of detecting suceptibility to breast cancer through mutations in the fgfr3 and tp53 genes
CN104035889B (zh) * 2014-06-18 2017-02-22 中国人民解放军信息工程大学 一种多态路由派生方法及系统
US10867705B2 (en) * 2014-11-06 2020-12-15 Ancestryhealth.Com, Llc Predicting health outcomes
US9859394B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US10020300B2 (en) 2014-12-18 2018-07-10 Agilome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
CA2971589C (en) 2014-12-18 2021-09-28 Edico Genome Corporation Chemically-sensitive field effect transistor
US10006910B2 (en) 2014-12-18 2018-06-26 Agilome, Inc. Chemically-sensitive field effect transistors, systems, and methods for manufacturing and using the same
US9618474B2 (en) 2014-12-18 2017-04-11 Edico Genome, Inc. Graphene FET devices, systems, and methods of using the same for sequencing nucleic acids
US9857328B2 (en) 2014-12-18 2018-01-02 Agilome, Inc. Chemically-sensitive field effect transistors, systems and methods for manufacturing and using the same
EP3459115A4 (en) 2016-05-16 2020-04-08 Agilome, Inc. GRAPHEN-FET DEVICES, SYSTEMS AND METHODS FOR USE THEREOF FOR SEQUENCING NUCLEIC ACIDS
US11810672B2 (en) * 2017-10-12 2023-11-07 Nantomics, Llc Cancer score for assessment and response prediction from biological fluids
TWI661198B (zh) * 2018-01-26 2019-06-01 長庚大學 診斷或預斷人類口腔癌的方法
CN113707222A (zh) * 2021-07-28 2021-11-26 邢传华 用于预测预定疾病风险的方法、计算设备和存储介质

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092900A1 (en) * 2005-10-26 2007-04-26 Stacey Simon N Methods for diagnosing and characterizing breast cancer and susceptibility to breast cancer
WO2008117314A2 (en) * 2007-03-26 2008-10-02 Decode Genetics Ehf Genetic variants on chr2 and chr16 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
EA018444B1 (ru) * 2007-05-25 2013-08-30 Декоуд Дженетикс Ехф. ГЕНЕТИЧЕСКИЕ ВАРИАНТЫ В Chr 5p12 И 10q26 В КАЧЕСТВЕ МАРКЕРОВ ДЛЯ ПРИМЕНЕНИЯ ПРИ ОЦЕНКЕ РИСКА, ДИАГНОСТИРОВАНИИ, ПРОГНОЗИРОВАНИИ И ЛЕЧЕНИИ РАКА ГРУДИ
EP2215253B1 (en) * 2007-09-26 2016-04-27 Navigenics, Inc. Method and computer system for correlating genotype to phenotype using population data
WO2009097270A2 (en) * 2008-01-28 2009-08-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Method of determining breast cancer risk
CA2729934A1 (en) * 2008-07-07 2010-01-14 Decode Genetics Ehf Genetic variants for breast cancer risk assessment

Also Published As

Publication number Publication date
EP2721180A1 (en) 2014-04-23
WO2012172575A1 (en) 2012-12-20
EP2721180A4 (en) 2015-09-02
US20140329719A1 (en) 2014-11-06

Similar Documents

Publication Publication Date Title
IL276488B (en) A method for predicting breast cancer prognosis
HK1197085A1 (en) Genetic variants for predicting risk of breast cancer
EP2686443A4 (en) GENETIC VARIANTS USEFUL IN ESTIMATING THE RISK OF THYROID CANCER
IL228738A0 (en) Antibodies for cancer treatment
HK1201413A1 (en) Treatment of breast cancer
HK1254859A1 (zh) 治療乳腺癌的方法
HK1197182A1 (en) Cancer immunotherapy
EP2691547A4 (en) GENE EXPRESSION PREDICTORS FOR CANCER PROSPECTS
EP2698634A4 (en) BIOMARKER FOR BREAST CANCER
GB201102014D0 (en) Method for predicting risk of developing cancer
EP2648754A4 (en) METHODS OF INHIBITING THE METASTASIS OF CANCER
EP2707710A4 (en) DIAGNOSIS OF CANCER
IL228430A0 (en) Cancer treatment
GB201120860D0 (en) Cancer immunotherapy
EP2894477A4 (en) METHOD FOR DETECTION OF BREAST CANCER
GB2510539B (en) Biomarkers of cancer
EP2771695A4 (en) METHOD OF DETECTION OF BREAST CANCERS
EP2649225A4 (en) BIOMARKERS FOR THE PREDICTION OF BREAST CANCER
EP2732287A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER
GB201103407D0 (en) Genetic association
EP2769225A4 (en) BIOLOGICAL MARKERS PREDICTIVE FOR BREAST CANCER
IL229109A0 (en) Cancer diagnosis
AP3297A (en) Direct electrowinning of cobalt
GB201121783D0 (en) Treatment of cancer
GB201222952D0 (en) Treatent of cancer